October 25, 2019
LIPAC Oncology Announces Successful Completion of Phase 1 Bladder Cancer Clinical Study and Initiation of Phase 2A Study
September 16, 2019
LIPAC ONCOLOGY AND HUONS CO. ANNOUNCE EXCLUSIVE LICENSING AGREEMENT FOR TBC-1002 IN KOREA
January 9, 2017
TESORX ANNOUNCES CREATION OF LIPAC ONCOLOGY AND ADVANCEMENT OF ONCOLOGY PIPELINE
Developments solidify company leadership position and expansion of cancer treatments